or
forgot password
  • cancer clinical trials in detroit, MI

  • BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
    Wayne State University
    Detroit, Michigan 48202
    Renal Cell Carcinoma
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Lymphoma
    ARCHER 1009 : A Study Of PF-00299804 (Dacomitinib) Vs. Erlotinib In The Treatment Of Advanced Non-Small Cell Lung Cancer
    Pfizer Investigational Site
    Detroit, Michigan 48201
    Non-Small Cell Lung Cancer (NSCLC)
    Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Metastatic Pancreatic Adenocarcinoma
    A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung Cancer
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Non Small Cell Lung Cancer
    Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients
    Wayne State University/Karmanos Cancer Institute Study Coordinator
    Detroit, Michigan 48201
    Advanced Solid Tumors,, Selected Solid Tumors
    Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia
    Pfizer Investigational Site
    Detroit, Michigan 48201
    Acute Lymphocytic Leukemia
    Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
    Wayne State University
    Detroit, Michigan 48202
    Extensive Stage Small Cell Lung Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor, Recurrent Breast Cancer, Recurrent Melanoma, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Small Cell Lung Cancer, Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor, Stage IV Breast Cancer, Stage IV Melanoma, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
    Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
    Barbara Ann Karmanos Cancer Institute

    Trial Locations
    Barbara Ann Karmanos Cancer Institute
    Josephine Ford Cancer Center at Henry Ford Hospital
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer
    Henry Ford Health System
    Detroit, Michigan 48202
    Head and Neck Cancer
    S0927: Omega-3-Fatty Acid Supplements in Treating Muscle and Bone Pain and Stiffness in Pts W/Stage I, II, or III Breast Cancer Receiving Hormone Therapy
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Arthralgia, Breast Cancer, Pain
    MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
    Children's Hospital of Michigan
    Detroit, Michigan 48201
    Acute Myeloid Leukemia
    Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Wayne State University
    Detroit, Michigan 48202
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer Subjects
    Karmanos Cancer Center
    Detroit, Michigan 48201
    Oral Mucositis
    Association Between Hepatitis C Infection and Renal Cell Carcinoma
    Henry Ford Hospital
    Detroit, Michigan 48202
    Hepatitis C, Renal Cell Carcinoma, Colorectal Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Wayne State University

    Trial Locations
    Wayne State University
    Saint John Hospital and Medical Center
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Tacrolimus and ATG as GVHD Prophylaxis in Patients Undergoing Related Donor HSCT
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Waldenstrom Macroglobulinemia
    PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Metastatic Renal Cell Carcinoma, Metastatic Melanoma
    Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Lymphoma, Neurotoxicity, Therapy-related Toxicity
    Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer)
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Colorectal Cancer, Cancer of Pancreas, Pancreatic Neoplasm, Malignant Neoplasm of Large Intestine, Malignant Tumor of Colon, Colon Carcinoma, Cancer of Colon, Pancreatic Cancer
    Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
    Wayne State University/Children's Hospital of Michigan
    Detroit, Michigan 48201
    Sturge-Weber Syndrome
    Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Prostate Cancer
    A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Acute Lymphoblastic Leukemia (ALL)
    MSC2015103B in Solid Tumors
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Advanced Solid Tumor
    A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Urologic Neoplasms, Metastatic Bladder Cancer, Urinary Tract Neoplasms
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Multiple Myeloma
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    Children's Hospital of Michigan

    Trial Locations
    Children's Hospital of Michigan
    Local Institution
    Leukemia, Pediatric
    Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Acute Lymphoblastic Leukemia
    Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
    Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    Saint John Hospital and Medical Center
    Detroit, Michigan 48236
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
    Henry Ford Hospital
    Detroit, Michigan 48202
    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma
    Study of ABT-700 in Subjects With Advanced Solid Tumors
    Site Reference ID/Investigator# 57555
    Detroit, Michigan 48201
    Advanced Solid Tumors
    Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
    Henry Ford Hospital
    Detroit, Michigan 48202
    Brain and Central Nervous System Tumors
    GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
    Henry Ford Hospital
    Detroit, Michigan 48202
    Breast Cancer, Brain Metastases
    A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
    Henry Ford Health System

    Trial Locations
    Henry Ford Health System
    Karmanos Cancer Institute
    Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    Henry Ford Health Systems

    Trial Locations
    Henry Ford Health Systems
    Detroit Medical Center
    ST Segment Elevation Myocardial Infarction
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    Josephine Ford Cancer Center at Henry Ford Hospital
    Detroit, Michigan 48202
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    Wayne State University
    Detroit, Michigan 48202
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Fosaprepitant Dimeglumine in Preventing Nausea and Vomiting in Patients With Gastrointestinal Cancer Receiving Combination Chemotherapy
    Barbara Ann Karmanos Cancer Institute
    Detroit, Michigan 48201
    Gastrointestinal Cancer, Nausea Post Chemotherapy
    Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)
    Henry Ford Health System
    Detroit, Michigan 48202
    Metastatic Colorectal Cancer, Colorectal Cancer
    Decision Aid to Technologically Enhance Shared Decision Making
    Morang Chester Clinic

    Trial Locations
    Morang Chester Clinic
    David Williams, MD
    Andrew Thomas, MD
    Rice Lanzilote & Egan
    Colorectal Cancer
    Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine
    Karmanos Cancer Institute
    Detroit, Michigan 48201
    Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
    Azacitidine With or Without Lenalidomide or Vorinostat in Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
    Wayne State University
    Detroit, Michigan 48202
    Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
    A Study Of The Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
    Henry Ford Hospital
    Detroit, Michigan 48202
    Well-differentiated Pancreatic Neuroendocrine Tumor